Collegium Pharmaceutical Inc (COLL)
Net profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 69,190 | 88,594 | 99,893 | 93,294 | 48,155 | 9,016 | -11,161 | -29,359 | -25,002 | -42,837 | -35,248 | 42,786 | 71,517 | 103,509 | 106,749 | 41,964 | 26,752 | 17,593 | 198 | -12,572 |
| Revenue (ttm) | US$ in thousands | 631,449 | 599,245 | 576,653 | 566,923 | 566,767 | 546,642 | 536,946 | 524,949 | 463,933 | 361,675 | 313,505 | 272,898 | 276,868 | 325,777 | 326,110 | 321,226 | 310,016 | 307,948 | 301,714 | 298,696 |
| Net profit margin | 10.96% | 14.78% | 17.32% | 16.46% | 8.50% | 1.65% | -2.08% | -5.59% | -5.39% | -11.84% | -11.24% | 15.68% | 25.83% | 31.77% | 32.73% | 13.06% | 8.63% | 5.71% | 0.07% | -4.21% |
December 31, 2024 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $69,190K ÷ $631,449K
= 10.96%
Collegium Pharmaceutical Inc's net profit margin has shown fluctuation over the reported periods. The margin started in negative territory in March 2020 but gradually improved to reach a peak of 32.73% in June 2021. However, there was a sharp decline thereafter, with negative margins reported for several consecutive quarters until March 2024. The margin then saw a notable rebound, reaching 17.32% in June 2024 before slightly decreasing to 10.96% by December 2024. This pattern suggests that Collegium Pharmaceutical Inc has experienced periods of profitability followed by challenges impacting its bottom line, indicating potential shifts in business operations or market conditions during the analyzed period.
Peer comparison
Dec 31, 2024